{"altmetric_id":4686594,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["National Institute of Allergy and Infectious Diseases (NIAID)"],"first_seen_on":"2015-10-28T12:10:59+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1436349600,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02337868"],"nct_id":"NCT02337868","pubdate":"2015-01-08T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Phase 1 Trial of Inactivated West Nile Virus Vaccine","type":"clinical_trial_study_record"},"altmetric_score":{"score":48.256,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":48.256},"context_for_score":{"all":{"total_number_of_other_articles":5328647,"mean":6.2427593279806,"rank":108130,"this_scored_higher_than_pct":97,"this_scored_higher_than":5220659,"rank_type":"exact","sample_size":5328647,"percentile":97},"similar_age_3m":{"total_number_of_other_articles":195791,"mean":10.268607109658,"rank":8633,"this_scored_higher_than_pct":95,"this_scored_higher_than":187158,"rank_type":"exact","sample_size":195791,"percentile":95},"this_journal":{"total_number_of_other_articles":14218,"mean":7.0061602307097,"rank":235,"this_scored_higher_than_pct":98,"this_scored_higher_than":13984,"rank_type":"exact","sample_size":14218,"percentile":98},"similar_age_this_journal_3m":{"total_number_of_other_articles":758,"mean":10.748335535007,"rank":28,"this_scored_higher_than_pct":96,"this_scored_higher_than":730,"rank_type":"exact","sample_size":758,"percentile":96}}},"demographics":[],"counts":{"total":{"posts_count":6},"news":{"unique_users_count":4,"unique_users":["medical_news_today","eurekalert","upi_com","technology_org"],"posts_count":4},"blogs":{"unique_users_count":2,"unique_users":[55704,55633],"posts_count":2}},"posts":{"news":[{"title":"West Nile Virus vaccine to enter safety trials in humans","url":"http:\/\/www.medicalnewstoday.com\/articles\/296460.php","license":"public","citation_ids":[4686594],"posted_on":"2015-07-08T10:00:00+00:00","summary":"A vaccine to protect people from West Nile Virus is to enter safety trials after lab tests showed it protected mice against lethal doses of the virus.","author":{"name":"Medical News Today","url":"http:\/\/www.medicalnewstoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/040\/normal\/medical_news_today.png?1369846932"}},{"title":"NIH-funded vaccine for West Nile Virus enters human clinical trials","url":"http:\/\/www.eurekalert.org\/pub_releases\/2015-07\/nioa-nvf070615.php","license":"public","citation_ids":[4686594],"posted_on":"2015-07-06T04:00:00+00:00","summary":"( NIH\/National Institute of Allergy and Infectious Diseases ) A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the NIAID. The experimental vaccine was discovered and developed by s","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}},{"title":"West Nile vaccine to enter clinical trial","url":"http:\/\/www.upi.com\/Health_News\/2015\/07\/06\/West-Nile-vaccine-to-enter-clinical-trial\/3801436214650\/","license":"public","citation_ids":[4686594],"posted_on":"2015-07-06T21:39:07+00:00","summary":"Stephen Feller BETHESDA, Md., July 6 (UPI) -- The NIH announced a clinical trial to test the safety of a West Nile vaccine in humans that protected mice from lethal doses of the virus in lab tests.","author":{"name":"UPI.com","url":"http:\/\/upi.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/057\/normal\/upi_com.png?1369846942"}},{"title":"NIH-funded vaccine for West Nile virus enters human clinical trials","url":"http:\/\/www.technology.org\/2015\/07\/07\/nih-funded-vaccine-west-nile-virus-enters-human-clinical-trials\/","license":"public","citation_ids":[4686594],"posted_on":"2015-07-07T15:10:43+00:00","summary":"A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be The post NIH-funded vaccine for West Nile virus enters human clinical trials has been published on Technology Org .","author":{"name":"Technology.org","url":"http:\/\/www.technology.org","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/499\/normal\/Screen_Shot_2016-02-03_at_09.22.48.png?1454491380"}}],"blogs":[{"title":"Clinical Trial Testing West Nile Vaccine","url":"http:\/\/sciencebusiness.technewslit.com\/?p=26931","license":"public","citation_ids":[4686594],"posted_on":"2015-05-07T21:11:00+00:00","summary":"(CDC.gov)\n7 May 2015. A vaccine for West Nile virus, a seasonal infection spread by mosquitoes, is being tested for safety in an early stage clinical trial. The vaccine, code-named HydroVax-001, is being developed in the lab of microbiologist Mark Slifka a","author":{"name":"Science and Enterprise","url":"http:\/\/sciencebusiness.technewslit.com","description":"Science for business people. Enterprise for scientists."}},{"title":"NIH-funded vaccine for West Nile virus enters human clinical trials","url":"http:\/\/www.nih.gov\/news\/health\/jul2015\/niaid-06.htm","license":"public","citation_ids":[4686594],"posted_on":"2015-07-06T19:37:00+00:00","summary":"A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).","author":{"name":"NIH News Releases","url":"http:\/\/www.nih.gov\/news\/","description":"News releases from the National Institutes of Health (NIH)"}}]}}